Latest Ratings for FIVN Date Firm Action From To Feb 2022 Needham Maintains Buy Feb 2022 Keybanc Maintains Overweight Feb 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for FIVN View the Latest Analyst Ratings read more
Latest Ratings for DY Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 UBS Initiates Coverage On Buy Nov 2021 B. Riley Securities Maintains Buy View More Analyst Ratings for DY View the Latest Analyst Ratings read more
Latest Ratings for T Date Firm Action From To Mar 2022 TD Securities Downgrades Buy Hold Feb 2022 JP Morgan Upgrades Neutral Overweight Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for T View the Latest Analyst Ratings read more
Latest Ratings for CDNS Date Firm Action From To Feb 2022 JP Morgan Maintains Neutral Feb 2022 Berenberg Upgrades Hold Buy Feb 2022 Rosenblatt Maintains Buy View More Analyst Ratings for CDNS View the Latest Analyst Ratings read more
HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ease and HSA growth continues. Latest Ratings for HQY Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Dec 2021 JP Morgan Maintains Overweight Dec 2021 Deutsche Bank Maintains Buy View More Analyst Ratings for HQY…
The meme coin market is slowly bottoming, with top meme coins showing the best returns for traders. read more
Latest Ratings for NICE Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Jefferies Maintains Buy Dec 2021 Morgan Stanley Downgrades Overweight Equal-Weight View More Analyst Ratings for NICE View the Latest Analyst Ratings read more